Bexarotene
- Product NDC
- 42291-072
- 11-digit product format
- 422910072
- Labeler code
- 42291
- Product ID
- 42291-072_41163fef-69b8-4e09-e063-6294a90ac8ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bexarotene
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA210105
- Marketing category
- ANDA
- Marketing start
- 2023-04-14
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| A61RXM4375 | BEXAROTENE | 153559-49-0 | BEXAROTENE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42291-072-01 | 42291007201 | 100 CAPSULE in 1 BOTTLE (42291-072-01) | 100 capsule | 2023-04-14 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Bexarotene | AvKARE | 2025-10-13 | HUMAN PRESCRIPTION DRUG LABEL | 2 |
| Bexarotene | AvKARE | 2023-04-14 | HUMAN PRESCRIPTION DRUG LABEL | 1 |